Journal
JOURNAL OF MOLECULAR ENDOCRINOLOGY
Volume 63, Issue 3, Pages R51-R72Publisher
BIOSCIENTIFICA LTD
DOI: 10.1530/JME-18-0274
Keywords
GDM; pathophysiology; inflammation; placenta; transcription factors
Categories
Funding
- Department of Obstetrics and Gynaecology (University of Melbourne)
- University of Melbourne
- Australian Government Research Training Program (RTP) Scholarship
- Scholarship of Public Service Department of Malaysia (JPA)
- NHMRC [454310]
- Norman Beischer Medical Research Foundation
- Diabetes Australia
- Melbourne Research Grant Scheme (MRGS)
- ANZ Charitable Trust (Medical Research and Technology Grant)
- Mercy Research Foundation
- Lions Medical Research Foundation
- National Health and Medical Research Council (NHMRC) [1114013]
- Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1170809]
Ask authors/readers for more resources
Gestational diabetes mellitus (GDM) imposes serious short- and long-term health problems for mother and baby. An effective therapeutic that can reduce the incidence of GDM and improve long-term maternal and fetal outcomes is a major research priority, crucially important for public health. A lack of knowledge about the underlying pathophysiology of GDM has hampered the development of such therapeutics. What we do know, however, is that maternal insulin resistance, low-grade inflammation and endothelial cell dysfunction are three central features of pregnancies complicated by GDM. Indeed, data generated over the past decade have implicated a number of candidate regulators of insulin resistance, inflammation and endothelial cell dysfunction in placenta, maternal adipose tissue and skeletal muscle. These include nuclear factor-kappa B (NF-kappa B), peroxisome proliferator-activated receptors (PPARs), sirtuins (SIRTs), 5' AMP-activated protein kinase (AMPK), glycogen synthase kinase 3 (GSK3), PI3K/mTOR, inflammasome and endoplasmic reticulum (ER) stress. In this review, the identification of these as key modulators of GDM will be discussed. The biochemical pathways involved in the formation of these may represent potential sites for intervention that may translate to therapeutic interventions to prevent the development of GDM.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available